D-Galactosamine-Induced Mouse Hepatic Apoptosis : Possible Involvement with Tumor Necrosis Factor, but not with Caspase-3-Activity
スポンサーリンク
概要
- 論文の詳細を見る
We investigated whether tumor necrosis factor (TNF) and caspase-3 activity are involved in the induction of hepatocellular apoptosis in D-galactosamine (D-GalN)-induced hepatotoxicity in mice. Acute hepatotoxicity was induced by the intraperitoneal injection of D-GalN into female BALB/c mice. D-GalN (0.75-3.0 g/kg) increased the serum blutamate pyruvate transaminase (s-GPT) activity and the percentage of liver DNA fragmentation, an indicator of hepatotoxicity, after 48 h, in a dose-dependent manner. Furthermore, after D-GalN (3.0 g/kg) administration, increased liver DNA fragmentation was detected biochemically at 24 h, then increased s-GPT activity accompanied by increased liver DNA fragmentation was observed after 48 h. The serum TNF (s-TNF) level and the TNF mRNA expression in the liver after D-GalN (3.0 g/kg, i.p.) administration were examined by an ELISA kit and reverse transcription polymerase chain reaction (RT-PCR), respectively, to investigate the relation between the s-GPT activity and liver DNA fragmentation. The s-TNF level and TNF mRNA expression in the liver after D-GalN (3.0 g/kg) administration were detected earlier than liver DNA fragmentation, then increased with time. However, there was almost no association of caspase-3 activity with the increase in liver DNA fragmentation. Increases in the s-TNF level, TNF mRNA expression and the percentage of DNA fragmentation in the liver and s-GPT activity were inhibited by dexamethasone (Dex; 0.4-2.5 mg/kg, i.p.) in a dose-dependent manner. Based on these findings, it was considered that the intracellular apoptosis signal in D-GalN-induced hepatotoxicity in mice did not depend on caspase-3 activity, and that other signals mediated by TNF may be involved.
- 公益社団法人日本薬学会の論文
- 1999-10-15
著者
-
Omata Takeshi
Department Of Applied Research Central Laboratories Zeria Pharmaceutical Co. Ltd.
-
SEGAWA Yoshihide
Department of Pharmacology, Central Research Laboratories, Zeria Pharmaceutical Co., Ltd.,
-
SEGAWA Yoshihide
Zeria Pharmaceutical Co., Ltd.
-
ITOKAZU Yoshihiko
Zeria Pharmaceutical Co., Ltd.
-
INOUE Naonori
Zeria Pharmaceutical Co., Ltd.
-
Inoue N
Zeria Pharmaceutical Co. Ltd.
-
ITOKAZU Yoshihiko
Department of Applied Research, Central Laboratories, Zeria Pharmaceutical Co., Ltd.,
-
INOUE Naonori
Department of Applied Research, Central Laboratories, Zeria Pharmaceutical Co., Ltd.,
-
Segawa Y
Zeria Pharmaceutical Co. Ltd.
-
Segawa Yoshihide
Department Of Pharmacology Central Research Laboratories Zeria Pharmaceutical Co. Ltd.
-
Itokazu Y
Zeria Pharmaceutical Co. Ltd.
関連論文
- Z-100,Extracted from Mycobacterium tuberculosis Strain Aoyama B, Inhibits the Development of Collagen-Induced Arthritis in Mice
- Possible Changes in Expression of Chemotaxin LECT2 mRNA in Mouse Liver after Concanavalin A-Induced Hepatic Injury
- D-Galactosamine-Induced Mouse Hepatic Apoptosis : Possible Involvement with Tumor Necrosis Factor, but not with Caspase-3-Activity
- Fasting Exacerbates Acute Pancreatitis by Occlusion of the Common Bile Duct in Rats
- Diet Stimulation as a Synergistic Factor of Aggravation in a Pancreatic Bile Duct Ligation-Induced Rat Pancreatitis Model
- Cholecystokinin Acts as an Essential Factor in the Exacerbation of Pancreatic Bile Duct Ligation-Induced Rat Pancreatitis Model Under Non-fasting Condition
- Antiallergic Effect of ZCR-2060: Antihistaminic Action.
- Autoradiographic Localization of Human Calcitonin Sensitive Binding Sites in Rat Brain.
- Antiallergic Effects of ZCR-2060: Effect on Allergic Cutaneous Reactions and Rhinitis Models in Mice and Rats.